GILL SIMBA (President & CEO) sold 10.6% of their position (2K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $7.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/29/2023ACC: 0001694665-23-000160
DirectorOfficer· President & CEO
Since Jan 2019
+58K
Net shares
Net buyer
$7.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
75K acquired · 17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
399.6%
9/27/2023
3.75K→18.75K
Common Stock
Direct
Shares
−2K
Price / share
$3.94
Trade value
$7.86K
% of position
10.6%
9/28/2023
18.75K→16.76K
Total
Net shares
+13K
Net value
-$7.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/27/2023 | M · Option Exercise | +15K | — | — | 399.6% | 3.75K | 18.75K |
| Common Stock Direct | 9/28/2023 | S · Sale | −2K | $3.94 | $7.86K | 10.6% | 18.75K | 16.76K |
| Total | +13K | -$7.86K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
60K shares
Shares
+60K
Strike price
Held after
60K
Exercisable
—
9/27/2023
Restricted Stock Units
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
Held after
45K
Exercisable
—
9/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock60K shares | 9/27/2023 | A · Award | +60K | — | 60K | |
| Restricted Stock Units Direct | Common Stock15K shares | 9/27/2023 | M · Option Exercise | −15K | — | 45K |